Skip to content

Effect of Emotional Freedom Technique on Perceived Pain, Situational Anxiety and Satisfaction Levels During Mammography Screening.

The Effect of the Emotional Freedom Technique Applied During Mammography Screening on Perceived Pain, Situational Anxiety and Satisfaction Levels

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06296927
Enrollment
94
Registered
2024-03-06
Start date
2024-11-07
Completion date
2025-03-30
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Mammography Screening, Pain

Keywords

mammography, pain, Emotional Freedom Technique

Brief summary

This study was planned to determine the effect of Emotional Freedom Technique on perceived pain level, situational anxietyl and satisfaction level during mammography screening.

Detailed description

The randomized controlled and experimental study will be conducted with 94 women who applied to the Cancer Early Diagnosis, Screening and Education Center for mammography screening. The women in the experimental group (n=47) will be applied the Emotional Freedom Technique before mammography screening and the women in the control group (n=47) will be given routine mammography screening. The Sociodemographic Information Form, Visual Analog, Situational Anxiety Inventory, blood pressure monitor, thermometer and saturation device will be used to collect the data.

Interventions

OTHEREmotional Freedom Technique

The researcher will apply the Emotional Freedom Technique to women in the intervention group who apply for mammography screening for 30-40 minutes before the screening.

Sponsors

Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

The study is a randomized controlled two-group study.

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Having a first mammography screening * Knowing how to read and write, * Having entered menopause (at least 1 year has passed since the last menstruation)

Exclusion criteria

* Having any cognitive or hearing problems, * Having used painkillers before the procedure, * Having no chronic diseases (cardiovascular, respiratory tract), * Having a diagnosed mental illness (schizophrenia, bipolar disorder), * Having epilepsy (as it is a contraindication for EFT applications),

Design outcomes

Primary

MeasureTime frameDescription
Anxiety20 minuteData will be collected using the State Anxiety Inventory. The answer options collected in four classes on the State Anxiety Inventory scale are: (1) Not at all, (2) A little, (3) A lot and (4) Completely; The options on the trait anxiety scale are (1) Rarel, (2) Sometimes, (3) A lot of the time, and (4) Almost always. The higher the score obtained from the scales, the higher the person's anxiety is. The total score obtained from the scale varies between 20-80, and 20-39 indicates a mild anxiety level, 40-59 indicates a medium anxiety level, 60-79 indicates a high anxiety level, and 80 points indicates a panic anxiety level.
Pain Level10 minuteData will be collected using the Visual Analogue Scale. Pain can be given a score between 0 and 10 on the scale.The higher the scale score, the greater the pain.

Secondary

MeasureTime frameDescription
Satisfaction Level10 minutesData will be collected using the Visual Analog Scale. Satisfaction can be given a score between 0 and 10 on the scale. The higher the scale score, the higher the satisfaction level.
Blood Pressure5 minutesThe data will be measured with a blood pressure monitor, and the average normal value in blood pressure measurement will be accepted as 120/80 mmHg.
Thermometer5 minutesData will be measured from the forehead with a fever measuring device and the average normal value in body temperature measurement will be accepted as 36.5-37.5.
Saturation5 minutesData will be measured from the fingertip with a saturation device and the average normal value of the measurement will be accepted as between 95-100%.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 4, 2026